This presentation will examine the widespread availability and use of derived intoxicating cannabis products, including delta-8 THC, despite state and federal regulatory efforts. The session will highlight the health risks associated with these products, particularly synthetically derived cannabinoids, and the predatory marketing practices targeting youth. It will also analyze the limitations of current state regulations and bans, emphasizing the gaps in enforcement and legal loopholes that enable continued sales. Information will be provided on the specific legal language, advocacy strategies, and enforcement measures needed to effectively address this issue at the federal, state, and local levels. The presentation will conclude with a discussion on strategies to support related public health efforts.
